circomax myco
zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologiques pour les suidés - les porcs (pour l'engraissement) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection. onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination. duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination. in addition, vaccination has been shown to reduce body weight gain losses under field conditions.
actrapid 100 ui/ml, solution injectable en multidose
novo nordisk pharmaceutique sas - insuline humaine recombinante - solution - 100 ui - composition pour 1 ml > insuline humaine recombinante : 100 ui
actrapid 40 u.i./ml, solution injectable en multidose
novo nordisk pharmaceutique sas - insuline humaine recombinante - solution - 40 ui - composition pour 1 ml > insuline humaine recombinante : 40 ui
actrapid penfill 100 ui/ml, solution injectable en cartouche de 1,5 ml
novo nordisk pharmaceutique sas - insuline humaine recombinante - solution - 100 ui - composition pour 1 ml > insuline humaine recombinante : 100 ui
insulatard nph 100 ui/ml, suspension injectable en multidose
novo nordisk pharmaceutique sas - insuline humaine recombinante isophane - suspension - 100 ui - composition pour 1 ml > insuline humaine recombinante isophane : 100 ui
insulatard nph 40 u.i./ml, suspension injectable en multidose
novo nordisk pharmaceutique sas - insuline humaine recombinante isophane - suspension - 40 ui - composition pour 1 ml > insuline humaine recombinante isophane : 40 ui
insulatard nph penfill 100 ui/ml, suspension injectable en cartouche de 1,5 ml
novo nordisk pharmaceutique sas - insuline humaine recombinante isophane - suspension - 100 ui - composition pour 1 ml > insuline humaine recombinante isophane : 100 ui
mixtard 10 penfill 100 ui/ml, suspension injectable en cartouche de 1,5 ml
novo nordisk pharmaceutique sas - insuline humaine recombinante isophane biphasique - suspension - 100 ui - composition pour 1 ml > insuline humaine recombinante isophane biphasique : 100 ui
mixtard 20 penfill 100 ui/ml , suspension injectable en cartouche de 1,5 ml
novo nordisk pharmaceutique sas - insuline humaine recombinante isophane biphasique - suspension - 100 ui - composition pour 1 ml > insuline humaine recombinante isophane biphasique : 100 ui
mixtard 30 100 ui/ml, suspension injectable en multidose
novo nordisk pharmaceutique sas - insuline humaine recombinante isophane biphasique - suspension - 100 ui - composition pour 1 ml > insuline humaine recombinante isophane biphasique : 100 ui